Keywords: enrollment, well, track, ph, iii, tlt, trial

Enrollment "well on track" for Ph III TLT trial

Article | 28 January 2008

Print This

Swiss biotechnology firm Arpida has initiated patient screening for enrolment into a pivotal Phase III study of its TLT treatment ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in